Turn Therapeutics Inc. TTRX
9.51 USD -0.14 (-1.45%)
At closeNov 3, 2026, 4:00 PM EST
9.51 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
9.46 Day range 10.33
2.57 52-week range 16.45
- YTD
- +141.37%
- 1 year
- +115.16%
Financial health
Altman Z-Score
7.88 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -17.1×
FY 2022 5y median -31.2× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 11.6×
FY 2022 5y median 45.7× FY 2025
P/FCF -19.9×
FY 2022 5y median -64.8× FY 2025
EV/EBITDA -15.6×
FY 2022 5y median -31.2× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -5.0%
FY 2022 5y median -1.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -68.2%
FY 2022 5y median -219.6% FY 2025
ROIC -94.4%
FY 2022 5y median -139.5% FY 2025
ROA -26.3%
FY 2022 5y median -100.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -226.0%
FY 2022 FY 2025
EPS (diluted) -76.9%
FY 2022 FY 2025
Free Cash Flow -85.9%
FY 2022 FY 2025
Financial Health
Current Ratio 0.9×
FY 2022 5y median 1.4× FY 2025
Quick Ratio 0.9×
FY 2022 5y median 1.4× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 1.6×
FY 2022 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31